Volume 24, Number 4—April 2018
Dispatch
Emergomyces canadensis, a Dimorphic Fungus Causing Fatal Systemic Human Disease in North America
Table
Case no. |
Year |
Location |
Patient age, y/sex |
Medical history |
Clinical syndrome |
Specimen cultured |
Treatment |
Outcome |
Strain ID† |
---|---|---|---|---|---|---|---|---|---|
1 |
1992 |
Regina, Saskatchewan |
68/M |
HIV |
Sepsis, skin lesions |
Skin biopsy |
– |
Died |
UAMH 7172 (AF038322) |
2 |
2003 |
Saskatoon, Saskatchewan |
39/M |
Kidney transplant, diabetes |
Pneumonia, tracheitis, lymphadenopathy, esophagitis, sepsis |
Blood, BAL fluid |
Fluconazole, then
amphotericin B |
Survived |
UAMH 10370 (EF592151) |
3 |
2010 |
Colorado Springs, Colorado |
75/F |
– |
Fungemia, endocervical lesion |
Blood |
– |
Died |
UTHSCSA DI17–85 (MG777526, MG777527) |
4 | 2015 | Santa Fe, New Mexico | 40/M | HIV | Pneumonia, skin lesions, sepsis | Skin biopsy | – | Survived | UTHSCSA DI17–84 (MG777530, MG777528) |
*BAL, bronchoalveolar; ID, identification; UAMH, UAMH Centre for Global Microfungal Biodiversity; UTHSCSA, University of Texas Health Science Center at San Antonio; –, data missing.
†GenBank accession numbers for relevant nucleotide sequences are given.
Page created: March 19, 2018
Page updated: March 19, 2018
Page reviewed: March 19, 2018
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.